SINOVAC BIOTECH LTD financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2023.

Symbol
SVA on Nasdaq
Location
Beijing
Fiscal year end
31 December
Latest financial report
29 Apr 2024

Quick Takeaways

  • SVA - SINOVAC BIOTECH LTD financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2023.
  • Headline metric summary will appear when SEC facts are available.

What Changed

  • No metrics are currently available for comparison on this facts page.
  • Changes will populate automatically as new 10-Q/10-K periods are processed.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

n/a

Insufficient Data Confidence low

Financial Health

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 99,638,043 +0.14%
Common Stock, Shares, Outstanding 99,638,043 +0.14%
Common Stock, Value, Issued $100,000 0%

Additional Metrics

Metric Latest value YoY change
Cash and Cash Equivalents, at Carrying Value $1,270,131,000 -70%
Accounts Receivable, after Allowance for Credit Loss, Current $440,019,000 -18%
Inventory, Net $139,874,000 -23%
Assets, Current $11,830,556,000 -2.4%
Deferred Income Tax Assets, Net $29,790,000 -58%
Property, Plant and Equipment, Net $979,617,000 -1.4%
Operating Lease, Right-of-Use Asset $45,525,000 -22%
Intangible Assets, Net (Excluding Goodwill) $8,520,000 -12%
Other Assets, Noncurrent $7,345,000 +163%
Assets $13,657,974,000 -3.2%
Employee-related Liabilities, Current $643,855,000 +107%
Accrued Liabilities, Current $250,565,000 +3.3%
Liabilities, Current $1,147,904,000 +5.2%
Deferred Income Tax Liabilities, Net $263,711,000 +9.2%
Operating Lease, Liability, Noncurrent $39,271,000 -25%
Other Liabilities, Noncurrent $439,000 +83%
Liabilities $1,635,207,000 +17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $490,055,000 -28%
Retained Earnings (Accumulated Deficit) $7,118,516,000 -1.5%
Stockholders' Equity Attributable to Parent $8,709,418,000 -2.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $12,022,767,000 -5.4%
Liabilities and Equity $13,657,974,000 -3.2%
Common Stock, Shares Authorized 100,000,000 0%
Common Stock, Shares, Issued 99,638,043 +0.14%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,275,297,000 -70%
Deferred Tax Assets, Valuation Allowance $100,665,000 +494%
Operating Lease, Liability $45,077,000 -23%
Lessee, Operating Lease, Liability, to be Paid $55,792,000 -42%
Property, Plant and Equipment, Gross $1,456,209,000 +16%
Operating Lease, Liability, Current $5,806,000 -3.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,038,000 -46%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,024,000 -27%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10,715,000 -72%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,961,000 -35%
Preferred Stock, Shares Issued 14,630,813 0%
Preferred Stock, Shares Authorized 50,000,000 0%
Unrecognized Tax Benefits $0 -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,221,000 -32%
Preferred Stock, Shares Outstanding 14,630,813 0%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY